AVR 4.08% $12.49 anteris technologies ltd

Ann: DurAVR first successful implantation Valve-in-Valve, page-21

  1. 13,950 Posts.
    lightbulb Created with Sketch. 131
    Third dot point on page 10 talks about whether a comparable device meets the needs of patients. Seeing as that comparable device has failed, requiring a VIV, can we not argue we are offering non-comparable benefits (hemodynamics, etc)?
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.